Učitavanje...
DIPG-75. INTERSECTION OF EPIGENETICS AND IMMUNITY IN DIPG
Improved therapy for DIPG represents an urgent unmet clinical need. No meaningful improvement has been made in over 30 years, with palliative radiation leading to a median survival of just 1 year. Immune checkpoint inhibitors are an important new therapeutic modality, showing success in many adult c...
Spremljeno u:
| Izdano u: | Neuro Oncol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6012243/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.167 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|